|
2024
|
Invention
|
Treatment of cataplexy.
The present invention relates to a method of treating cataplexy in a sub... |
|
|
Invention
|
Compound having oxadiazole and pharmaceutical composition containing the same.
Disclosed are oxa... |
|
|
Invention
|
Tricyclic compound and use thereof as mat2a inhibitor. The present application relates to a tricy... |
|
|
Invention
|
Methods for treating attention-deficit/hyperactivity disorder.
The invention is directed to a me... |
|
|
Invention
|
Parenteral liquid preparation comprising carbamate compound.
The present invention relates to a ... |
|
|
Invention
|
Use of carbamate compound for prevention, alleviation or treatment of status epilepticus.
The pr... |
|
|
Invention
|
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the s... |
|
|
Invention
|
Mirna-484 inhibitors and uses thereof. The present disclosure includes the use of a miR-484 inhib... |
|
2023
|
Invention
|
Seizure management system and method thereof. A seizure management system disclosed herein: detec... |
|
|
Invention
|
Method for detection and/or predicting epileptic seizure on basis of continuous biosignal measure... |
|
|
Invention
|
Novel tricyclic compound as kras g12d inhibitor, and use thereof. The present application relates... |
|
|
Invention
|
Pharmaceutical combination of prmt5 inhibitor and dna damage-inducing substance. The present disc... |
|
|
Invention
|
Compound for shp2 protein degradation and medical uses thereof. The present disclosure provides a... |
|
|
Invention
|
Pharmaceutical composition comprising pyridone derivatives.
A pyridone derivative compound and a... |
|
|
Invention
|
Treatment of sleep-wake disorders. This invention is directed to a method of treating Excessive d... |
|
|
Invention
|
Treatment of cataplexy. The present invention relates to a method of treating cataplexy in a subj... |
|
|
Invention
|
Blend containing carbamate compound for prevention, mitigation, or treatment of schizophrenia.
T... |
|
|
Invention
|
Bicyclic compound and use thereof.
The present disclosure relates to a compound derivative conta... |
|
|
Invention
|
Wearable device capable of measuring eeg and ecg for long time. A wearable device comprises a sen... |
|
|
Invention
|
N-oxide compounds and use thereof. The present disclosure provides a compound represented by Form... |
|
|
Invention
|
Use of [(1r)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate in combination therapy.
The pr... |
|
|
G/S
|
Medicines for human purposes and veterinary preparations for the treatment of central nervous sys... |
|
|
Invention
|
Aminocarbonylcarbamate compounds.
The present disclosure provides a compound represented by Form... |
|
|
Invention
|
Oral pharmaceutical composition comprising carbamate compound and preparation method therefor.
T... |
|
|
Invention
|
Compound having oxadiazole and pharmaceutical composition containing the same. Disclosed are oxad... |
|
2022
|
Invention
|
Compositions comprising (r)-2-amino-3-phenylpropyl carbamate and uses thereof.
The present inven... |
|
|
Invention
|
Treatment for obesity. The present invention relates to a method for treating or preventing obesi... |
|
|
Invention
|
Use of carbamate compound for preventing, alleviating or treating myotonia.
The present inventio... |
|
|
Invention
|
Methods for treating autism spectrum disorders (asd).
The present disclosure relates generally t... |
|
|
Invention
|
Methods for treating autism spectrum disorders (asd). The present disclosure relates generally to... |
|
|
Invention
|
Oral aqueous suspension formulation comprising carbamate compound. The present disclosure relates... |
|
|
Invention
|
Oral aqueous suspension formulations comprising carbamate compound. The present disclosure relate... |
|
2021
|
Invention
|
Method for preparing aryl 2-tetrazol-1-yl keto with improved selectivity.
The present disclosure... |
|
|
Invention
|
Use of carbamate compound for preventing or treating trigeminal neuralgia.
The present invention... |
|
|
Invention
|
Blend containing carbamate compound for prevention, mitigation, or treatment of schizophrenia. Th... |
|
|
Invention
|
Solid oral composition comprising carbamate compound, and preparation method therefor.
The prese... |
|
|
Invention
|
Solid oral composition comprising carbamate compound, and preparation method therefor. The presen... |
|
|
G/S
|
Medical information; providing healthcare and medical information; providing medical information,... |
|
|
Invention
|
Bicyclic compound and use thereof. The present disclosure relates to a compound derivative contai... |
|
2020
|
G/S
|
Pharmaceutical and veterinary preparations; pharmaceuticals;
chemical preparations for pharmaceu... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of epilepsy; pharmaceutical products for the treatm... |
|
|
G/S
|
Pharmaceuticals for the treatment of epilepsy; chemical preparations for pharmaceutical purposes,... |
|
|
Invention
|
Bicyclic compound and use thereof.
The present invention relates to a 6-6 bicyclic ring-containi... |
|
|
Invention
|
Use of imidazopyrimidine or imidazotriazine compound for prevention, alleviation, or treatment of... |
|
|
Invention
|
Use of imidazopyrimidine or imidazotriazine compounds for prevention, alleviation, or treatment o... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; pharmaceuticals; chemical preparations for pharmaceut... |
|
|
G/S
|
Medical services in the field of epilepsy; providing medical information in the field of epilepsy... |
|
2019
|
G/S
|
Immunomodulators; human vaccines; vitamin preparations; preparations of trace elements for human ... |
|
|
G/S
|
Immunomodulators; vaccines; vitamin preparations;
preparations of trace elements for human and a... |
|
|
Invention
|
Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy ... |
|
|
Invention
|
Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating... |
|
|
G/S
|
Medicines for human purposes and veterinary preparations; dietetic food and substances for veteri... |
|
|
G/S
|
Medicines for human purposes and veterinary preparations for treatment of central nervous system ... |
|
2018
|
G/S
|
Medicines for human purposes and veterinary preparations;
dietetic foods adapted for medical pur... |
|
|
Invention
|
Use of carbamate compound for preventing, alleviating or treating myotonia. The present invention... |
|
|
G/S
|
Medicines for human and veterinary preparations for the treatment of cancer and central nervous s... |
|
|
G/S
|
Pharmaceutical and veterinary preparations for treatment of central nervous system diseases, canc... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; dietetic food and substances for veterinary purposes;... |
|
2017
|
G/S
|
Pharmaceutical and veterinary preparations for the treatment of cancer, central nervous system di... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; dietetic food
and substances for medical or veterina... |
|
|
G/S
|
Pharmaceutical [ and veterinary ] preparations for treatment of central nervous system diseases [... |
